NCT06837519 Lidocaine and Dexmedetomidine Infusion and Their Combination on Perioperative Pain in Patients Undergoing Video-Assisted Thoracoscopic Surgery
| NCT ID | NCT06837519 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Lidocaine |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-02-20 |
| Primary Completion | 2025-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2025-02-20 with a primary completion date of 2025-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare lidocaine and dexmedetomidine infusion and their combination on perioperative pain in patients undergoing video-assisted thoracoscopic surgery.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years old. * Both sexes. * American Society of Anesthesiologists (ASA) physical status of I, II. * Patients undergoing video-assisted thoracoscopic surgery (VATS) under general anesthesia. Exclusion Criteria: * Hypersensitivity to any of the used drugs. * Coagulation disorder. * Body mass index \>35 kg/m2. * History of chronic pain requiring daily opioids/steroids/clonidine/other α2 agonist/analgesics or any drugs acting on the central nervous system during the previous 2 weeks, and drug/alcohol abuse. * Contraindication to the use of local anesthetics. * Cardiovascular disease. * Severe respiratory, renal or hepatic impairment. * Insulin-dependent diabetes mellitus. * Central nervous system or psychiatric disease.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06837519 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lidocaine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06837519 currently recruiting?
Yes, NCT06837519 is actively recruiting participants. Contact the research team at Sarah606060@gmail.com for enrollment information.
Where is the NCT06837519 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06837519 clinical trial?
NCT06837519 is sponsored by Ain Shams University. The trial plans to enroll 75 participants.